Boundless Bio, Common Stock Analysis

BOLD Stock  USD 3.88  0.30  7.18%   
Boundless Bio, Common is overvalued with Real Value of 3.72 and Hype Value of 4.02. The main objective of Boundless Bio, stock analysis is to determine its intrinsic value, which is an estimate of what Boundless Bio, Common is worth, separate from its market price. There are two main types of Boundless Bio,'s stock analysis: fundamental analysis and technical analysis.
The Boundless Bio, stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Boundless Bio,'s ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boundless Bio, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Boundless Stock Analysis Notes

About 40.0% of the company shares are held by institutions such as insurance companies. The company had not issued any dividends in recent years. Boundless Bio, Common had 1:25 split on the March 31, 2011. Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases caused by single gene defects. Audentes Therapeutics, Inc. was founded in 2012 and is headquartered in San Francisco, California. Audentes Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 207 people. For more info on Boundless Bio, Common please contact Zachary Hornby at (858) 766-9912 or go to https://boundlessbio.com.

Boundless Bio, Common Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Boundless Bio,'s investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Boundless Bio, Common or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Boundless Bio, generated a negative expected return over the last 90 days
Boundless Bio, has high historical volatility and very poor performance
Net Loss for the year was (49.43 M) with profit before overhead, payroll, taxes, and interest of 0.
Boundless Bio, Common currently holds about 351.46 M in cash with (46.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.68, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Boundless Bio, has a frail financial position based on the latest SEC disclosures

Boundless Largest EPS Surprises

Earnings surprises can significantly impact Boundless Bio,'s stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2017-08-10
2017-06-30-0.79-0.87-0.0810 
2018-11-06
2018-09-30-0.88-0.97-0.0910 
2017-03-09
2016-12-31-0.75-0.91-0.1621 
View All Earnings Estimates

Boundless Bio, Environmental, Social, and Governance (ESG) Scores

Boundless Bio,'s ESG score is a quantitative measure that evaluates Boundless Bio,'s performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Boundless Bio,'s operations that may have significant financial implications and affect Boundless Bio,'s stock price as well as guide investors towards more socially responsible investments.

Boundless Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 301.12 M.

Boundless Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.38)(0.40)
Return On Capital Employed(0.45)(0.48)
Return On Assets(0.38)(0.40)
Return On Equity 0.39  0.41 

Management Efficiency

Boundless Bio, Common has return on total asset (ROA) of (0.3313) % which means that it has lost $0.3313 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5293) %, meaning that it created substantial loss on money invested by shareholders. Boundless Bio,'s management efficiency ratios could be used to measure how well Boundless Bio, manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 0.41, whereas Return On Tangible Assets are forecasted to decline to (0.40). At present, Boundless Bio,'s Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 2.02, whereas Non Currrent Assets Other are forecasted to decline to about 527.2 K.
Last ReportedProjected for Next Year
Book Value Per Share(5.71)(5.43)
Tangible Book Value Per Share(5.71)(5.43)
Enterprise Value Over EBITDA 0.40  0.42 
Enterprise Value Multiple 0.40  0.42 
Enterprise Value-21.5 M-20.4 M
The analysis of Boundless Bio,'s management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Boundless Bio,'s future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Boundless Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Return On Assets
(0.33)
Return On Equity
(0.53)

Technical Drivers

As of the 18th of July 2024, Boundless Bio, shows the Mean Deviation of 5.44, risk adjusted performance of (0.1), and Standard Deviation of 7.1. Boundless Bio, Common technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Boundless Bio, Common standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Boundless Bio, Common is priced correctly, providing market reflects its regular price of 3.88 per share. Given that Boundless Bio, has information ratio of (0.19), we suggest you to validate Boundless Bio, Common's prevailing market performance to make sure the company can sustain itself at a future point.

Boundless Bio, Common Price Movement Analysis

Execute Study
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Boundless Bio, middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Boundless Bio, Common. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Boundless Bio, Common Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Boundless Bio, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Boundless Bio,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Boundless Bio, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Boundless Bio, Predictive Daily Indicators

Boundless Bio, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Boundless Bio, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Boundless Bio, Forecast Models

Boundless Bio,'s time-series forecasting models are one of many Boundless Bio,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Boundless Bio,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Boundless Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Boundless Bio, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Boundless shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Boundless Bio,. By using and applying Boundless Stock analysis, traders can create a robust methodology for identifying Boundless entry and exit points for their positions.
Last ReportedProjected for Next Year

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Boundless Bio, to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Complementary Tools for Boundless Stock analysis

When running Boundless Bio,'s price analysis, check to measure Boundless Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio, is operating at the current time. Most of Boundless Bio,'s value examination focuses on studying past and present price action to predict the probability of Boundless Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio,'s price. Additionally, you may evaluate how the addition of Boundless Bio, to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Directory
Find actively traded commodities issued by global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stocks Directory
Find actively traded stocks across global markets